All In Biotech

Free tool

FAERS Monitor: Cupric Chloride In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018960 or its brand name (Cupric Chloride In Plastic Container, Cupric Chloride). Reports on generic versions are filed under their own applications.

Reports

748

Serious

502

67% of reports

Hospitalization

224

Death reported

42

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue75
  • off label use74
  • headache64
  • nausea64
  • pain61
  • diarrhoea60
  • drug ineffective53
  • weight decreased49
  • malaise43
  • abdominal pain40
  • anaemia37
  • dizziness36
  • dyspnoea36
  • constipation32
  • urinary tract infection29

Reports by year received

View as table
YearReports
20041
20054
20061
20073
20084
20096
20109
201114
201213
201321
201421
201532
201660
201723
201846
201957
202052
202165
202270
202366
202464
202569
202647

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,411 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anaemiaSignal375.54.0131
weight decreasedSignal494.93.8152
abdominal painSignal404.83.6119
urinary tract infectionSignal294.83.384
constipationSignal324.12.973
headacheSignal642.92.378
painSignal612.82.270
malaiseSignal432.82.147
fatigueSignal752.72.282
diarrhoeaSignal602.62.160
off label useSignal742.41.960
nauseaSignal642.31.846
dizzinessSignal362.01.518
dyspnoea361.81.312
drug ineffective531.10.91

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.